Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 74, Issue 23, Pages 4293-4303Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-017-2648-0
Keywords
Periostin; Matricellular protein; Allergy; Biomarker; Asthma; Atopic dermatitis; Allergic conjunctivitis; Scleroderma; Pulmonary fibrosis; Epithelial/mesenchymal interaction; Cross-talk; IL-4; IL-13; TGF-beta
Categories
Funding
- Grants-in-Aid for Scientific Research [15K15372, 16H05343, 16K09926] Funding Source: KAKEN
Ask authors/readers for more resources
We found for the first time that IL-4 and IL-13, signature type 2 cytokines, are able to induce periostin expression. We and others have subsequently shown that periostin is highly expressed in chronic inflammatory diseasesaEuro center dot asthma, atopic dermatitis, eosinophilc chronic sinusitis/chronic rhinosinusitis with nasal polyp, and allergic conjunctivitis-and that periostin plays important roles in the pathogenesis of these diseases. The epithelial/mesenchymal interaction via periostin is important for the onset of allergic inflammation, in which periostin derived from fibroblasts acts on epithelial cells or fibroblasts, activating their NF-kappa B. Moreover, the immune cell/non-immune cell interaction via periostin may be also involved. Now the significance of periostin has been expanded into other inflammatory or fibrotic diseases such as scleroderma and pulmonary fibrosis. The cross-talk of periostin with TGF-beta or pro-inflammatory cytokines is important for the underlying mechanism of these diseases. Because of its pathogenic importance and broad expression, diagnostics or therapeutic drugs can be potentially developed to target periostin as a means of treating these diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available